Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Overview of attention for article published in The Lancet, August 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 27 news outlets
blogs: 2 blogs
twitter: 145 X users

patent: 3 patents
facebook: 1 Facebook page
f1000: 1 research highlight platform

Citations

dimensions_citation: 603 Dimensions

Readers on

mendeley: 286 Mendeley

Summary News Blogs X Patents Facebook Research highlights Dimensions citations

So far, Dimensions has found 603 publications that cite this research output.

603

The most recent citing publications are shown below. View all 603 publications that cite this research output on Dimensions.

Impact of renal denervation on quality of life how does renal denervation contribute to improving hypertension treatment affected by poor medication adherence?

Article in Hypertension Research (April 2024)

A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study

Article in Cardiovascular Revascularization Medicine (April 2024)

Exploring Potential Referral Pathways for Renal Artery Denervation and Developing a Centre of Excellence in Ireland

Article in SN Comprehensive Clinical Medicine (March 2024)